MNK Inhibitor AUM001 in Combination With Either Pembrolizumab or Irinotecan to Treat Metastatic Colorectal Cancer
NCT 05462236 Brief Summary The study is a 2-part study of Tinodasertib…
Read more arrow_forwardNCT 05462236 Brief Summary The study is a 2-part study of Tinodasertib…
Read more arrow_forwardNCT 02645149 Brief Summary This is a patient oriented translational research project…
Read more arrow_forwardACTRN 12623000902695 Brief Summary This study is investigating the feasibility, safety and…
Read more arrow_forwardNCT 03787602 Brief Summary This study evaluates KRT-232, a novel oral small…
Read more arrow_forwardNCT 04830124 Brief Summary This study observes the antitumor activity, safety,…
Read more arrow_forwardNCT 05024318 Brief Summary This is a prospective, open label, phase II,…
Read more arrow_forwardNCT 05025813 Brief Summary Cutaneous Squamous Cell Carcinoma (cSCC) is typically…
Read more arrow_forwardACTRN 12621001529831 Brief Summary This trial is for patients with primary mediastinal…
Read more arrow_forwardACTRN 12623000620628 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardNCT 05020678 Brief Summary This is a single arm, open-label, multi-center, Phase…
Read more arrow_forward